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1. INTRODUCTION
Abnormal activation of microglial cells has been
implicated in various neurodegenerative and
autoimmune diseases. Myelin basic protein (MBP)1
accounts for approximately 30% of central nervous
system myelin proteins (Morell et al., 1989), and is
responsible for adhesion of the cytoplasmic surfaces
of the compact multilayered myelin sheath in the
central nervous system. Several peptide fragments of
MBP are formed in the brain during demyelinating
diseases. MBP contains three mitogenic regions (MBP
1–44, MBP 88–151, MBP 152–167) which in
conjugation with microglial secreted factors may
stimulate astrogliosis after demyelination in vivo
(South et al., 2000). MBP 1–44 and MBP 152–167
associate with ganglioside GM1 and bFGF receptor
respectively to stimulate Schwann cell proliferation
(Tzeng et al., 1999). Myelin basic protein itself
induces death of mature oligodendrocytes in vitro and
produces demyelination in vivo by a rapid and
dramatic rise of intracellular calcium, whereas MBP
peptides (1–44 or 88–151) cause only a modest and
transitory elevation of intracellular calcium ions, and
protects oligodendrocytes from death (Tzeng et al.,
1995, Althaus et al., 2000).
MBP peptide 45–89 (MBP 45–89), which
contains an immunodominant epitope, is detected in
body fluids after the degradation of MBP (Whitaker ,
1998). This peptide is released more rapidly from the
posttranslationally citrullinated isomer MBP C8 (also
denoted MBP Cit 6 in the literature) than from the
unmodified (MBP C1) isomer and has unusual
stability: the presence of secondary structure seems
to protect it from further enzymatic digestion, and
consequently it circulates in extracellular fluids for
rather a long time (Cao et al., 1999). The influence of
this peptide on the activity of glial cells is not known
at present.
In this study, we demonstrate that MBP peptide
45–89 significantly increased the production of NO
by microglia and reduced the viability of
oligodendrocytes/microglial primary cell cultures.
Western blot analysis was used to show that the
viability of these cells was correlated with the
decrease of IkB, the inhibitor of NF-kB, and the
induction of iNOS in the microglia.
2. MATERIALS AND METHODS
Preparation of MBP and MBP 45–89 peptide. MBP
was isolated and purified from bovine brain white
matter according to the method of Chou et al. [3],
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followed by HPLC. Briefly, the acid-soluble material
was dissolved in urea-glycine buffer, pH 9.6 and
applied to a CM-52 cellulose cation exchange column,
equilibrated in urea-glycine buffer, pH 10.5.
Following application of the sample, urea-glycine
buffer (pH 10.5) flow was continued until the first
big peak had completely eluted. This unbound fraction
is the least cationic isomer, i.e. MBP C8. For the
tryptic digestion MBP was suspended in 1 ml of 0.1
ammonium hydrogen carbonate, pH 8.0, containing
10 mM calcium acetate. A solution of trypsin
(0.3 mg/ml in  0.1 M hydrochloric acid) was added to
the protein suspension and the mixture was incubated
at 37  °C for 20–24 h (Martenson et al. 1981).  MBP
45–89 peptide were purified by HPLC as described
by Cao et al. (1999).
Cell cultures. Primary mixed glial cultures containing
astrocytes, microglia and oligodendrocytes were
prepared from whole brains of 2 day old Wistar rats.
The initial mixture of dissociated glial cells was
seeded in 75 cm2 flasks (2–3 brains/flask) coated with
poly-D-lysine. The cultures were maintained in
DMEM with 10% fetal calf serum and cultured for
48 h. This step provides a means of separating
adherent cells, such as microglia and astrocytes, from
nonadherent cells, such as oligodendrocytes. The
nonadherent oligodendrocyte fraction was plated into
poly-D-lysine-coated 25 cm2 flasks. For isolation of
microglial cells, confluent cultures between days 12
and 14 were agitated on a rotary shaker at 37  °C at
220 rpm for 1 h. The floating cells were collected
and incubated in tissue culture plates. After 1 h the
cultures were washed. The adherent cells were
identified as microglia. The astrocytes, i.e. the cells
remaining adherent after the removal of microglia,
were removed from the flasks by incubation with
0.25% trypsin for 10 min.
Cytotoxicity assays. To assess cell viability, a modified
3-(4,5-dimethylthiasol-2yl)-2,5 diphenyltetrazolium
bromide (MTT) assay, a sensitive first indicator of
oxidative damage (Liu et al., 1997), was carried out
as described by Liu et al. Briefly, 106 glial cells were
treated with 0.5 mg/ml MTT followed by incubation
at 37 0C for 2 h in a CO2 incubator. After brief
centrifugation, supernatants were carefully removed
and the formazan reaction product was dissolved in
acidic isopropanol. The formazan product was
quantified spectrophotometrically by its absorbance
at 570 nm. Data are presented as a percentage of the
absorbance obtained in untreated cultures, after
subtraction of blank values obtained by incubation
of MTT in medium alone. Trypan blue exclusion
assays were carried out after incubation (5 min before
counting) of cells with 0.04% trypan blue (Sigma).
Dead cells were stained blue. Three fields per
coverslip were counted for each experimental
condition, and between 100 and 200 cells were
counted on average per field. Statistical significance
was tested using the ANOVA computer program.
Assay for NO. Synthesis of NO was determined by
assaying the culture supernatants for nitrite (Pahan et
al., 2000). Briefly, 400 µl of culture supernatant was
allowed to react with 200 µl of Griess reagent (Green
et al., 1982) and incubated at room temperature for
15 min. The optical density of the assay samples was
measured spectrophotometrically at 570 nm.  Fresh
culture medium served as the blank in all experiments.
Western blot analysis. Following 24 h of incubation
in the presence or absence of MBP 45–89 peptide,
cells were removed from the dishes, washed with PBS
and homogenized in 50 mM Tris-HCl, pH 7.4,
containing protease inhibitors (1 mM PMSF, 5 µg/ml
aprotinin, 5 µg/ml pepstatin A, and 5 µg/ml leupeptin).
After electrophoresis, the proteins were transferred
onto a nitrocellulose membrane. Membranes were
treated with a horseradish peroxidase-conjugated
secondary antibody (Santa Cruz Biotechnology, USA)
and immunoreactivity was detected by enhanced
chemiluminescence autoradiography (ECL kit,
Amersham) in accordance with the manufacturer’s
instructions. The following primary antibodies (Santa
Cruz Biotechnology) were used: against IkB, against
iNOS, and against cytochrome c. Protein
concentrations were determined using a BCA protein
assay kit (Pierce).
Detection of cytochrome c release. Approximately
107 cells were trypsinized and collected by centri-
fugation. The cell pellets were washed with PBS and
resuspended in 125 µl buffer containing 250 mM
sucrose, 20 mM Hepes-KOH (pH 7.5), 10 mM KCl,
1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 1 mM
dithiothreitol, and 0.1 mM phenylmethylsulphonyl
fluoride (PMSF). The cells were then homogenized
and the mitochondria-enriched fraction was pelleted
by centrifugation at  15 000  rpm for 15 minutes. The
supernatant was subjected to Western blot analysis
with a monoclonal antibody against cytochrome c.
3. RESULTS
MBP 45–89-induces cell apoptosis in mixed primary
oligodendrocyte/microglial cell cultures
After continuous 24 h exposure of mixed
oligodendrocyte/microglial cells to 0.5 µM MBP 45–
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89 only about 65 % of the cells were still alive. In
contrast, MBP C8 at the same concentration is not
toxic to oligodendrocyte/microglial cells, as detected
by the MTT test and the trypan blue exclusion method
(Fig. 1A). Interestingly, the decrease of the viability
of cells takes place only in mixed oligodendrocyte/
microglial cultures, but not in pure cultures of
astrocytes, oligodendrocytes or microglia separately
(data not shown).
To examine whether the MBP 45–89-induced cell
death has apoptotic features, the release of mito-
chondrial cytochrome c into the cytosol was
determined. We isolated the cytosolic fractions from
oligodendrocyte/microglial cells treated or not with
MBP 45–89 and detected the released cytochrome c
by Western blot analysis. The exposure of oligo-
dendrocyte/microglial cells to 0.5 µM MBP 45–89
resulted in the release of cytochrome c from
mitochondria (Fig. 1B). Thus, MBP 45–89 appears
to induce apoptosis mainly via the mitochondrial
pathway.
MBP 45–89 induces  production of NO and activation
of NF-kB in microglial cell cultures
Nitric oxide, produced by inducible NO synthase
(iNOS), may play a central rôle in inflammatory
demyelinating disease of the central nervous system.
NO derived from the activation of iNOS in astrocytes
and microglia under the influence of proinflammatory
cytokines is presumed to contribute to oligodendro-
cyte degeneration in demyelinating diseases (Merill
et al., 1993; Pahan et al., 2000). Because microglia
rather than astrocytes are implicated in demyelinating
pathology (Tran et al., 1997),  in the next series of
experiments we examined the effect of MBP 45–89
on the production of NO and activation of NF-kB in
microglial cell culture.
Fig. 2A shows that continuous exposure for 24 h
of primary microglial cells to MBP 45–89 markedly
increased production of NO. To understand the
mechanism of this stimulation, we examined the effect
of MBP 45–89 on the level of iNOS. Western blot
analysis with antibodies against iNOS clearly shows
that MBP 45–89-mediated nitrite production is
engendered by the induction of iNOS (Fig 2B). As
Figure 1. MBP 45–89 reduces cell viability and stimulates
release of cytochrome c from mitochondria in mixed oli-
godendrocyte/microglial cell cultures.
A: Oligodendrocyte/microglial cell viability after exposure
to 0.5 µM MBP 45–89 or 0.5 µM MBP C8 for 24 h as-
sessed by the MTT test.  All data were normalized to con-
trol values (untreated cells) of 100. Data are presented as
the means ± SEM of three independent experiments.
B: Western blot analysis of cytoplasmic fractions. Cells
were treated with 0.5 µM MBP 45–89 for 24 h and then
the cytoplasmic fraction was analyzed for cytochrome c by
an immunoblotting technique using an anti-cytochrome c
antibody.
Figure 2. MBP 45–89 stimulates production of nitric
oxide, degradation of IkB and induction of iNOS in micro-
glia primary culture cells.
A: Production of NO in primary microglia. Cells were
treated with 0.5 µM MBP 45–89 for 24 h and then the
yield of nitrite was measured in the supernatant. Data are
means  ± SEM of three independent experiments.
B: Western blot analysis of cell homogenate. Cells were
treated with 0.5 µM MBP 45–89 for 24 h and then the
homogenate was analyzed for IkB and iNOS proteins by
an immunoblotting technique using anti-IkB and anti-iNOS
antibodies.
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the activation of NF-kB is known to be necessary for
the transcription of iNOS gene in glial cells (Colasanti
and Persichini, 2000), we examined the effect of MBP
45–89 on the activation of NF-kB. For this purpose,
we determined the cytoplasmic levels of the inhibitory
IkB protein after treatment of microglial cells with
MBP 45–89. Western blot analysis with antibody
against IkB showed that MBP 45–89 decreased the
level of inhibitory protein (Fig. 2B).
All together, these results indicate that MBP 45–
89 induces the degradation of IkB, the subsequent
nuclear translocation of NF-kB, and induction of the
iNOS gene. The resulting elevated concentration of
nitric oxide causes the death of oligodendrocytes.
5. DISCUSSION
Several peptide fragments of MBP are formed
in the brain during demyelinating diseases, which,
together with proinflammatory cytokines, can
influence proliferation or damage of glial cells (Tzeng
et al., 1999; South et al., 2000). Myelin basic protein
induces cell death of mature oligodendrocytes in vitro
and produces demyelination in vivo accompanied by
a rapid and dramatic rise of intracellular calcium,
whereas MBP peptides (1–44 or 88–151) caused only
a modest and transitory elevation of intracellular
calcium ions (Tzeng et al., 1995, Althaus et al., 2000).
This knowledge is now extended by our finding that
the immunodominant peptide 45–89 induces damage
of oligodendrocytes by activation of microglial cells
and subsequent generation of nitric oxide.
NF-kB is the major transcriptional factor in iNOS
transcriptional induction occurring in glial cells
(Colasanti and Persichini, 2000). NF-kB is activated
in microglia during experimental autoimmune
encephalomyelitis(EAE).Pyrrolidine dithiocarba-
mate, an inhibitor of NF-kB activation, attenuates the
clinical symptoms of EAE (Pahan, 2000). Astrocytes
and microglia express inducible nitric oxide synthase
in mice with EAE, and microglial NO is more
cytopathic than astrocyte-derived nitric oxide (Tran
et al., 1997).  Our present results show that the most
stable immunodominant peptide from citrullinated
MBP C8 (45–89) induces activation of NF-kB and
transcription of iNOS, resulting in excessive release
of NO.
The molecular mechanism of action of MBP 45–
89 on microglial cells is presently unknown. MBP is
known to contain three mitogenic regions (MBP 1–
44, MBP 88–151, and MBP 152–167), which in
conjugation with microglial secreted factors may
stimulate astrogliosis in vivo, after demyelination has
taken place (South et al., 2000). MBP 1–44 and MBP
152–167 associate with ganglioside GM1 and bFGF
receptor respectively to stimulate Schwann cell
proliferation (Tzeng et al., 1999). Taking into account
that p21ras  is involved in the induction of nitric oxide
synthase and activation of NF-kB in glial cells (Pahan
et al., 2000), and that Ras-pathway inhibitors suppress
EAE (Karussis et al., 2001) it is possible to infer that
the Ras-signalling pathway participates in the action
of MBP 45–89 on microglial cells.
The source and nature of the antigen presented
initially to the immunocompetent cells remains
unclear. Cao et al. (1999) supposed that deimination
might be viewed as a first step in making available
encephalitogenic peptides in MS and immunogenic
peptides in rheumatoid arthritis. They postulate that
the generation of peptide 45–89 is directly related to
deimination of arginine to citrulline in MBP. On the
other hand Matute et al. (2001) have proposed that
some (presently unknown) myelin components, which
are initially liberated from oligodendrocytes after
glutamate-induced excytotoxicity, might activate
microglia, which then release proinflammatory
cytokines (TNF-α, IL-12), produce reactive oxygen
species, and generate in turn fatal feedbacks that kill
oligodendrocytes. It is thus probable that the stable
immunodominant peptide 45–89 from citrullinated
MBP C8, which via the NF-kB pathway induces
transcriptional activity of microglial iNOS gene and
produces toxic amounts of nitric oxide, directly
initiates autoimmunity.
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ABBREVIATIONS
DMEM: Dulbecco’s modified Eagle’s medium
EAE: experimental autoimmune encephalomyelitis
HPLC: high-pressure liquid chromatography
NF-kB: a nuclear factor kB
IkB: inhibitor of NF-kB
iNOS: inducible NO synthase
MBP: myelin basic protein
PBS: phosphate buffered saline
PMSF: phenylmethylsulphonyl fluoride
